Search Results - Keith Karcher

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    An Open-Label Extension Study of the Safety and Efficacy of Risperidone in Children and Adolescents with Autistic Disorder

    An Open-Label Extension Study of the Safety and Efficacy of Risperidone in Children and Adolescents with Autistic Disorder by Justine Kent, David Hough, Jaskaran Singh, Keith Karcher, Gahan Pandina

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Long-acting injectable risperidone <i>v.</i> olanzapine tablets for schizophrenia or schizoaffective disorder

    Long-acting injectable risperidone <i>v.</i> olanzapine tablets for schizophrenia or schizoaffective disorder by Nicholas A Keks, M. Ingham, Akbar Ali Khan, Keith Karcher

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy

    A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuro... by Aaron I. Vinik, Douglas Y. Shapiro, Christine Rauschkolb, Bernd Lange, Keith Karcher, Deborah Pennett, Mila Etropolski

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis

    Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis by Carlo Antozzi, Jeffrey T. Guptill, Vera Bril, Josep Gámez, Sven G. Meuth, Richard J. Nowak, Dianna Quan, Teresa Sevilla, Marie‐Hélène Jouvin, Jim Jin, Keith Karcher, Sindhu Ramchandren, Hong Sun, Leona Ling, Yaowei Zhu, Santiago Arroyo

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease

    Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease by Reisa A. Sperling, David Henley, Paul Aisen, Rema Raman, Michael Donohue, Karin Ernström, Michael S. Rafii, Johannes Streffer, Yingqi Shi, Keith Karcher, Nandini Raghavan, Yevgen Tymofyeyev, Jennifer Bogert, H. Robert Brashear, Gerald Novak, John Thipphawong, Ziad S. Saad, Hartmuth C. Kolb, Hany Rofael, Panna Sanga, Gary Romano

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: